As the Q3 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the patient monitoring industry, including Insulet (NASDAQ:PODD) and its peers.

Every year, millions of newborns—especially those born premature, underweight or sick—are at risk of neonatal hypoglycemia, a dangerous drop in blood sugar that can lead to seizures, brain injury and ...

Breakthroughs in optical sensing, like band-pass Raman spectroscopy, promise a future free from painful finger-prick blood ...

Researchers at the Massachusetts Institute of Technology have created a compact Raman spectroscopy device that measures blood ...

Artificial intelligence-enhanced wearable devices, such as continuous glucose monitors (CGMs), have dramatically improved the ...

Shining near-infrared light on a person’s skin helped scientists accurately track his blood glucose levels, offering a ...

MIT researchers developed a compact band-pass Raman spectroscopy device that noninvasively tracks glucose through the skin in ...

USA: MIT researchers have developed a noninvasive method to monitor glucose using Raman spectroscopy and have created a ...

Health care company Abbott is recalling approximately three million blood glucose sensors as there has been a fault found in ...

About 3 million glucose monitoring sensors were potentially affected by a production error that caused incorrect low glucose readings.

The new sensor developed by MIT researchers does not involve drawing patients’ blood to test for sugar levels.